5th International Conference on Heart and Cardiovascular Diseases

The third edition of Heart Congress returned to Dubai—but arrived as a measurably more ambitious event. Six named clinical tracks, dedicated workshop sessions, a faculty representing over 20 countries, and a companion webinar running simultaneously on the same dates reflected the conference's continued growth as a global platform for cardiovascular research and innovation.

Held on May 05–06, 2025, in Dubai, UAE, the 3rd International Conference on Heart and Cardiovascular Diseases was organized by Scientex Conferences under the theme, "Novel Progression Towards the Heart and Cardiovascular Research." Conducted in a hybrid format, the conference brought together cardiologists, researchers, clinicians, and healthcare professionals from around the world to exchange scientific knowledge, present groundbreaking research, and foster international collaborations.

Programme Highlights

Six Clinical Tracks Covering:

• Cardiovascular diseases, clinical cardiology, and cardiac emergency care
• Echocardiography, advanced cardiovascular imaging, and COVID-19 cardiac impact
• Vascular surgery, regenerative and translational cardiology, endovascular interventions
• Cardiovascular pharmacology, cardiomyopathy, genetic cardiac disorders, and electrophysiology
• Heart failure, hypertension, atrial fibrillation, and atherosclerosis
• Interventional cardiology, aneurysm, and current research in cardiology

Keynote Speakers:

• Tatsuya Nakao (Japan) — 9.5-year follow-up data on Frozen Elephant Trunk aortic arch repair
• Gustavo Samaja (Argentina) — balloon aortic valvuloplasty in the TAVI era
• Ruhul Abid (USA, Brown University) — myocardial function and perfusion in ischaemic heart disease
• Noureddin Sawan (Qatar) — modern treatment strategies for atrial fibrillation
• Claudio L Pereira da Cunha (Brazil) — physical activity and arterial hypertension in workers

Workshop Sessions:

• Fontan failure and heart transplantation
• Heart transplantation following prolonged ECMO
• Both led by Massimo Griselli, King Abdullah bin Abdulaziz Hospital, KSA

Notable Research Presented:

• AI-assisted echocardiography — EchoCLIP multimodal model
• Successful LV aneurysm surgery at 16% ejection fraction
• Community resuscitation initiative — Restart a Heart, Sri Lanka
• Psoriasis and atherosclerotic cardiovascular disease — systematic review and meta-analysis

A special note of gratitude goes to our outstanding moderators, Adriana-Simoneta Pimienta-Ibarra, National Institute of Respiratory Diseases, Mexico whose expertise and commitment played a vital role in the seamless execution and success of the sessions. Additionally, all participants were awarded CPD Accreditation Certificates, recognizing their dedication to continued professional development and lifelong learning in the field of cardiology.

Speaker Note

"It's a very friendly meeting. You have a big learning opportunity with time for sharing your experience and discussion. I strongly recommend attending this kind of event instead of the big congresses where we don't have time for anything — not even to ask a question."

— Gustavo Samaja, Policlinica Bancaria / Sanatorio Colegiales, Buenos Aires, Argentina

What Came Next

With growing international momentum, the series moved to Southeast Asia for the 4th International Conference on Heart and Cardiovascular Diseases, held in Kuala Lumpur, Malaysia, May 04–05, 2026.

The successful debut in Dubai set the stage for a larger international gathering in Bangkok. The second edition expanded the reach of Heart Congress by welcoming a broader community of cardiologists, researchers, clinicians, and healthcare professionals, further strengthening its role as a growing global platform for cardiovascular science and collaboration.

Held on May 09–10, 2024, in Bangkok, Thailand, the 2nd World Congress on Heart and Cardiovascular Diseases was organized by Scientex Conferences. Conducted in a hybrid format, the congress combined in-person and virtual participation, enabling worldwide engagement in scientific sessions, keynote presentations, and collaborative discussions. The programme was further extended through the 2nd International Webinar, held on May 16–17, 2024, continuing knowledge exchange across the global

What the Congress Delivered

Scale and Reach

• Nearly 60 speakers and delegates from 20+ countries
• Session moderators: Dzhwar Jamal (Iraq) and Keval Yerigeri (USA)
• Participants from Japan, India, South Korea, China, Russia, UK, USA, Greece, Kazakhstan, Bangladesh, Sri Lanka, Ecuador, Pakistan, Malaysia, Ireland, Thailand, Brazil, Australia, and more

Scientific Programme

• Keynotes on SGLT2 inhibitors in preventive cardiology (Douglas Duffee, USA), cardiotoxic effects of antitumour agents (Alexandros Tselepis, Greece), and aortic surgery outcomes (Tatsuya Nakao, Japan)
• Speaker sessions across structural heart disease, cardio-oncology, vascular medicine, cardiac imaging, heart failure, electrophysiology, hypertension, and emergency cardiology
• Real-world PCI outcome data from the National Heart Centre, Sri Lanka
• PCSK9 research in chronic kidney disease and haemodialysis patients
• Poster sessions covering empagliflozin's cardioprotective mechanisms and anthracycline-induced cardiotoxicity

We appreciate all of the speakers, delegates, and poster presenters who gave up their time to share their findings with our peer network. A heartfelt thanks goes to our exceptional moderators Dzhwar Jamal, Hawler Medical University, Iraq, and Keval Yerigeri, Case Western Reserve University, USA who were the pillars of our event's success. 

In Their Own Words

"You have collected every surgeon, cardiologist from all over across the world. I would like to express my gratitude and sincere thanks to the organizers who made this such a wonderful conference."

— Nitin Kumar Kashyap, All India Institute of Medical Sciences, India

What Came Next

Heart Congress 2024 directly inspired the 3rd International Conference on Heart and Cardiovascular Diseases, returning to Dubai, UAE, on May 05–06, 2025 with a more structured clinical track programme and the addition of dedicated workshop sessions.

The journey began in Dubai, where the 1st World Congress on Heart and Cardiovascular Diseases, organized by Scientex Conferences, brought together cardiovascular researchers, clinicians, academicians, and healthcare professionals from around the world under the Heart Congress banner for the very first time. What followed was two days of rigorous scientific discussions, cross-border collaboration, and meaningful networking, laying the foundation for an international cardiovascular community that has continued to grow with every subsequent edition.

Held on May 18-19, 2023, in Dubai, UAE, the inaugural congress was conducted in a hybrid format, allowing participants to join both in person and virtually. Guided by the theme, "Novel Progression Towards the Heart and Cardiovascular Research," the conference featured keynote presentations, scientific sessions, and research exchanges that promoted innovation and global collaboration in cardiovascular medicine. The scientific programme was further extended through the 1st International Webinar on Heart and Cardiovascular Diseases, held on May 25–26, 2023, enabling wider participation from the global healthcare community.

Congress Achievements

• 50+ cardiovascular experts from 15+ countries across six continents
• Keynote lectures delivered by Eduardo Marinho Tassi (Brazil), Irina A Mandel (Russia), Kaneez Fatima Shad (Australia), and Ahmad El Ouweini (UAE)
• Scientific sessions spanning arrhythmia, atherosclerosis, cardiac imaging, COVID-19 cardiovascular complications, hypertension, dyslipidemia, and structural heart disease
• Poster presentations covering acute coronary syndrome, cardiometabolic risk factors, and patient recovery after cardiac surgery
• Video presentations from Kazakhstan, Brazil, Egypt, France, and Portugal
• Companion webinar extended the scientific programme to global virtual participants one week after the in-person event

We extend a special note of thanks to our outstanding moderators, Salman M Malik from MedStar Medical Group Cardiovascular Associates, USA. Their unwavering expertise, commitment, and leadership were the cornerstone of our event's success, ensuring that each session was both insightful and impactful. 

A Speaker's Perspective

"This conference surpassed all my expectations and left an indelible impression on me both professionally and personally. Heart Congress 2023 has left an indelible mark on me, and I eagerly anticipate attending future conferences."

— Md Abir Tazim Chowdhury, Evercare Hospital Dhaka, Bangladesh

What Came Next

The success of the inaugural Dubai congress led directly to the 2nd World Congress on Heart and Cardiovascular Diseases, held in Bangkok, Thailand, May 09–10, 2024. We look forward to your gracious presence and valuable support in making our event a great success once again.